CHEN Jin*, LI Qiu-lan, LUO He-ping, LI Qin. *Department of Stomatology, Jiangxi Pingxiang People’s Hospital, Pingxiang 337000, China. Effects of glucocorticoid on osteoprotegerin expression in periodontal ligament cell.[J]. Acta Metallurgica Sinica.
[1] Edwards JR, Mundy GR. Advances in osteoclast biology: old findings and new insights from mouse models [J]. Nat Rev Rheumatol, 2011, 7(4):235-243.[2] Teng YT. Mixed periodontal Th1-Th2 cytokine profile in Actinobacillus actinomycetemcomitans-specific osteoprotegerin ligand (or RANK-L)- mediated alveolar bone destruction in vivo [J]. Infect Immun, 2002, 70(9):5269-5273.[3] Belibasakis GN, Bostanci N. The RANKL-OPG system in clinical periodontology [J]. J Clin Periodontol, 2012, 39(3):239-248.[4] Hou LT, Yaeger JA. Cloning and characterization of human gingival and periodontal ligament fibroblasts [J]. J Periodontol, 1993, 64(12):1209-1218.[5] Edwards JR, Mundy GR. Advances in osteoclast biology: old findings and new insights from mouse models [J].Nat Rev Rheumatol, 2011, 7(4):235-243.[6] Brabnikova Maresova K, Pavelka K, et al. Acute effects of glucocorticoids on serum markers of osteoclasts,osteoblasts, and osteocytes [J]. Calcif Tissue Int, 2013, 92(4):354-361. [7] Humphrey EL, Williams JH, Davie MW, et al. Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells [J]. Bone, 2006, 38(5):652-661. [8] Huang L, Xu J, Kumta SM, et al. Gene expression of glucocorticoid receptor alpha and beta in giant cell tumour of bone: evidence of glucocorticoid-stimulated osteoclastogenesis by stromal-like tumour cells [J]. Mol Cell Endocrinol, 2001, 181(1-2):199-206.[9] Hirayama T, Sabokbar A, Athanasou NA. Effect of corticosteroids on human osteoclast formation and activity [J]. J Endocrinol, 2002, 175(1):155-63.